SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Conclusion of Safety Study in Asthmatic Patients for MDT-637 and Presentation of Overall Phase 1 Results at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium